InvestorsHub Logo
Followers 16
Posts 1775
Boards Moderated 0
Alias Born 08/05/2008

Re: None

Thursday, 09/04/2008 1:05:01 PM

Thursday, September 04, 2008 1:05:01 PM

Post# of 1456
SARM - ?AIH

INTERVIEW-GTx says muscle drug holds promise
GTXI/CEO (INTERVIEW, UPDATE 1):INTERVIEW-UPDATE 1-GTx says muscle drug holds promise

http://www.forbes.com/feeds/reuters/2008/09/02/2008-09-02T213105Z_01_N02444336_RTRIDST_0_GTXI-CEO-INTERVIEW-UPDATE-1.html?partner=email

This statement does not account for the hypogonadism after androgen cessation!!! There have been no peer reviewed publications on these studies. However, in SARM publications they do state that LH is suppressed. “Selectivity with regard to gonadotropin suppression represents a significant barrier to the clinical use of SARMs.” [Gao W, Dalton JT. Ockham's Razor and Selective Androgen Receptor Modulators (SARMs): Are We Overlooking the Role of 5{alpha}-Reductase? Mol Interv 2007;7(1):10-3.] It will be interesting to view the results for the serum testosterone.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCT News